Bio-Path (BPTH) to Release Earnings on Friday

Bio-Path (NASDAQ:BPTH) is scheduled to release its earnings data before the market opens on Friday, November 15th. Analysts expect Bio-Path to post earnings of ($1.02) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Bio-Path (NASDAQ:BPTH) last posted its quarterly earnings results on Thursday, August 15th. The company reported ($1.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.54) by $0.38. During the same quarter last year, the business earned ($10.60) earnings per share. On average, analysts expect Bio-Path to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Bio-Path Stock Down 3.2 %

Shares of BPTH opened at $0.87 on Wednesday. The company has a 50-day simple moving average of $0.99 and a 200-day simple moving average of $1.61. Bio-Path has a 52 week low of $0.80 and a 52 week high of $12.40.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Bio-Path in a report on Friday, November 8th. They issued a “sell” rating for the company.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.